Related Experiment Video
Updated: May 13, 2026

11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Improving outcomes in patients with psoriasis
1Department of Dermatology, Royal Infirmary of Edinburgh, Edinburgh, UK.
The Practitioner
|March 9, 2013
Summary
Psoriasis is a chronic inflammatory skin condition affecting 1-2% of people. Severe psoriasis increases the risk of serious health issues like heart disease and diabetes, requiring comprehensive patient assessment and management.
Area of Science:
- Dermatology
- Immunology
- Public Health
Background:
- Psoriasis is a complex inflammatory disorder affecting skin and joints, impacting 1.3-2% of the global population.
- Key diagnostic features include characteristic silver scales, with exacerbations triggered by stress, infections, and certain medications.
- Severe psoriasis is linked to increased risks of metabolic syndrome and cardiovascular diseases, alongside other comorbidities.
Purpose of the Study:
- To provide a comprehensive overview of psoriasis, encompassing its diagnosis, triggers, associated health risks, and management strategies.
- To emphasize the importance of a holistic assessment of psoriasis severity, patient well-being, and comorbidities.
- To guide appropriate referral pathways for different psoriasis presentations and suspected complications.
Main Methods:
- Review of existing literature on psoriasis epidemiology, clinical presentation, and pathophysiology.
- Analysis of the relationship between psoriasis severity and associated systemic conditions.
- Outline of current management principles, including topical therapies and referral criteria.
Main Results:
- Plaque psoriasis diagnosis is typically straightforward, aided by characteristic skin lesions.
- Significant comorbidities associated with psoriasis include metabolic syndrome, cardiovascular disease, uveitis, and inflammatory bowel disease.
- Effective management hinges on patient adherence, minimal daily treatment regimens, and timely specialist referral when necessary.
Conclusions:
- Psoriasis management requires a multifaceted approach, considering physical, psychological, and social impacts.
- Early recognition of comorbidities and appropriate referral are crucial for optimal patient outcomes.
- Primary care can manage most cases, but specialist dermatological and rheumatological input is vital for severe or complex cases.
More Related Videos
Related Concept Videos
Guidelines for Writing Outcome
When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care evaluation by...
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care evaluation by...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
